What You Should Know for the 2014-2015 Influenza Season | Seasonal Influenza (Flu) | CDC

Read the full fact page: What You Should Know for the 2014-2015 Influenza Season | Seasonal Influenza (Flu) | CDC:

"People should begin getting vaccinated soon after flu vaccine becomes available, ideally by October, to ensure that as many people as possible are protected before flu season begins."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Five Steps That Men Can Take to Avert a Heart Attack - NBC News.com

Read the full article: Five Steps That Men Can Take to Avert a Heart Attack - NBC News.com:

"Men who take just five healthy steps can reduce their odds of a heart attack by four-fifths, but just 1 percent of men do so on their own, according to new research published Monday. The steps are nothing secret: They are not smoking, drinking moderately, exercising daily, eating a healthy diet and keeping the belly in check."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Related articles

• 
  Make GMP Training Effective - free tips
• 
  OK Folks, Get Walking! Huge Health Benefits
• 
  HDMA - Issues in Distribution: Pharmaceutical Traceability and the Drug Supply Chain Security Act
• 
  Industry groups take issue with guidance on outsourcing facilities

FDA to Middle-Aged Men: You Probably Don’t Need Testosterone Therapy - MensJournal.com

Read the full article: FDA to Middle-Aged Men: You Probably Don’t Need Testosterone Therapy - MensJournal.com:

" A recent study found that testosterone therapies doubled the heart attack risk for men over age 65 and for younger men with a history of heart disease after only three months of use. And in June the FDA began requiring drug manufacturers to include a warning label on product packaging, stating that these treatments may cause blood clots.

Schwartz says they may also increase PSA levels, an indicator of prostate cancer risk, although they haven’t been proven to increase the risk. “Given these potential harms and the fact that these are unproven therapies for men with low T of aging,” she says, “what’s going on right now is a huge uncontrolled experiment.”"

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Hallucinogen in 'magic mushrooms' helps longtime smokers quit in Hopkins trial | Hub

Read the full article: Hallucinogen in 'magic mushrooms' helps longtime smokers quit in Hopkins trial | Hub:

"Johns Hopkins researchers report that a small number of longtime smokers who had failed many attempts to drop the habit did so after a carefully controlled and monitored use of psilocybin—the active hallucinogenic agent in so-called "magic mushrooms"—in the context of a cognitive behavioral therapy treatment program.

The abstinence rate for study participants was 80 percent after six months, much higher than typical success rates in smoking cessation trials, says Matthew W. Johnson, an associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, and the corresponding author on the study."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Health Canada: We do not enforce the law when Canadians poison Americans - Searching for Safety

Read the full article: Health Canada: We do not enforce the law when Canadians poison Americans - Searching for Safety:

"Simply put, Health Canada admits that it does not intend to enforce the law on Canadian internet pharmacies that sell to foreigners.  We suspected this was the excuse, but now it’s official. As Health Canada’s response says:

Health Canada prioritizes its work according to the risk to health that the incident may pose to Canadians. Incidents that present a potentially higher risk to health will be actioned first. Incidents of low or nominal risk will be assessed and entered into our tracking system for possible future compliance action as deemed appropriate."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Related articles

• 
  Make GMP Training Effective - free tips
• 
  HDMA - Issues in Distribution: Pharmaceutical Traceability and the Drug Supply Chain Security Act
• 
  Your Florida CDR just quit. What do you do?
• 
  
  

New Influenza drug Peramivir by BioCryst Pharma Treats Flu in One Dose | Capital OTC

Updated July 29, 2021

The original link broke.

You can still read about this topic here"

FDA approves BioCryst's intravenous flu drug - Reuters

---  the original post follows below  ---

Read the full article: New Influenza drug Peramivir by BioCryst Pharma Treats Flu in One Dose | Capital OTC:

"According to latest studies, a single dose of new antiviral drug Peramivir is safe and effective in treating influenza in adults when it is administered within 48 hours of the appearance of the symptoms of Flu."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog

More deadly pathogens, toxins found improperly stored in NIH and FDA labs - The Washington Post

Read the full article: More deadly pathogens, toxins found improperly stored in NIH and FDA labs - The Washington Post:

"Officials at the National Institutes of Health said Friday a search on their sprawling Bethesda campus had turned up five different misplaced biological materials in recent weeks. All of them are considered so dangerous — they are known as “select agents” — that the government requires them to be stored in specially secured facilities. But in these cases, the vials were in regular labs, often part of collections of samples that date back decades.

Simultaneously, the Food and Drug Administration said it had found vials of staphylococcal enterotoxin, a frequent cause of food-borne illness, at a lab within the agency’s Center for Food Safety and Applied Nutrition that was not registered to handle it."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Biotechnology to the Rescue - US News

Read the full article: Biotechnology to the Rescue - US News:

"The life sciences industry is in the middle of a historic boom, churning out new medical weapons at an unprecedented pace. In 2012, the Food and Drug Administration approved 39 “new molecular entities,” completely novel drugs to treat everything from cancer to tuberculosis to HIV. It topped that off by adding 27 more last year, and there are now more than 4,000 investigational medicines in the pipeline.

Medical device-makers are also in high gear; the 33 products approved in 2013 include replacement hips, new cardiac stents and prosthetic spinal discs. Here’s a sampling of the most innovative developments transforming medical practice and offering patients new hope:"

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Company tests a way to deliver vaccines by a skin 'patch' - Boston Business Journal

Read the full article: Company tests a way to deliver vaccines by a skin 'patch' - Boston Business Journal:

"An Australian biotech startup with an office in Cambridge's Kendall Square has developed a way to deliver vaccines to patients without using a syringe or nasal mist. Vaxxas Inc. has developed the Nanopatch, which consists of thousands of vaccine-coated microprojections that penetrate the outer layers of a patient’s skin.

The nano-level sized microprojections are coated with vaccine and then released directly to key immune cells found just below the skin’s surface, according to Vaxxas CEO David Hoey."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog